Stephen J. Hoffman, Director at ALLOS THERAPEUTICS INC (ALTH), sold 40,000 shares at $9.68 ($387K) on 2008-09-02, disclosed to the SEC on 2008-09-03.
Scheduled sale ($387k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GNCA | BUY | 2014-02-11 | $3.0M | — | Filing → |
| DRNA | BUY | 2014-02-05 | $3.0M | — | Filing → |
| ACRX | BUY | 2012-05-31 | $968K | — | Filing → |